Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of the Currently Recommended Pneumococcal Vaccination Schedule in Patients With Chronic Lymphocytic Leukaemia.

NCT05145101 is registered in ClinicalTrials.gov with Hannah Garcia Garrido as lead sponsor.

NCT NCT05145101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05145101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of the Currently Recommended Pneumococcal Vaccination Schedule in Patients With Chronic Lymphocytic Leukaemia.
Lead sponsor
Hannah Garcia Garrido
Phase
Observational
Overall status
Unknown status
Start date
May 7, 2020
Completion date
March 31, 2022
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, invasive pneumococcal disease, recurrent isolated, pneumococcal infections, vaccine-preventable diseases